{"DataElement":{"publicId":"3528003","version":"1","preferredName":"New Tumor Post Resection Pathologic Length Value","preferredDefinition":"Numeric value for the length of the new tumor as examined pathologically at the time of the surgical resection.","longName":"3527931v1.0:3527937v1.0","context":"NCIP","contextVersion":"1","DataElementConcept":{"publicId":"3527931","version":"1","preferredName":"New Tumor Post Resection Pathologic Length","preferredDefinition":"Having no previous example or precedent or parallel; of a kind not seen before._A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias._Happening at a time subsequent to a reference time; later in time or order._The act of cutting out; the surgical removal of part or all of a structure or organ._A report that provides a description of the gross and microscopic examination of the specimen and is used to make a diagnosis and to determine treatment. It defines which structures and organs of the body are involved by the tumor, verifies the primary site of the cancer and describes the extent to which it has spread._The linear extent in space from one end of something to the other end, or the extent of something from beginning to end.","longName":"3108264v1.0:3527921v1.0","context":"NCIP","contextVersion":"1","ObjectClass":{"publicId":"3108264","version":"1","preferredName":"New Neoplasm","preferredDefinition":"New; having no previous example or precedent or parallel.:A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","longName":"C25586:C3262","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"New","conceptCode":"C25586","definition":"Having no previous example or precedent or parallel; of a kind not seen before.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm","conceptCode":"C3262","definition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8883C12C-4F39-5E58-E040-BB89AD437DB2","latestVersionIndicator":"Yes","beginDate":"2010-06-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-06-08","modifiedBy":"ONEDATA","dateModified":"2010-06-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"3527921","version":"1","preferredName":"Post Excision Pathology Report Length","preferredDefinition":"Happening at a time subsequent to a reference time; later in time or order.:The act of cutting out; the surgical removal of part or all of a structure or organ. :The description of cells and tissues made by a pathologist based on microscopic evidence, and sometimes used to make a diagnosis of a disease.:Length; the linear extent in space from one end to the other.","longName":"C38008:C15232:C28277:C25334","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Post","conceptCode":"C38008","definition":"Happening at a time subsequent to a reference time; later in time or order.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Excision","conceptCode":"C15232","definition":"The surgical removal of a lesion, often as part of a biopsy and with healthy margins.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Pathology Report","conceptCode":"C28277","definition":"A report that provides a description of the gross and microscopic examination of the specimen and is used to make a diagnosis and to determine treatment. It defines which structures and organs of the body are involved by the tumor, verifies the primary site of the cancer and describes the extent to which it has spread.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Length","conceptCode":"C25334","definition":"The linear extent in space from one end of something to the other end, or the extent of something from beginning to end.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C4F5B496-FD64-E567-E040-BB89AD432C45","latestVersionIndicator":"Yes","beginDate":"2012-07-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-07-16","modifiedBy":"ONEDATA","dateModified":"2012-07-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008548","version":"1","preferredName":"Tumor Measurements","preferredDefinition":"any measurements, including linear dimensions, volume, and weight, of a patient's tumor.","longName":"TUMOR_MSRMTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B228CD1A-3A0C-4C11-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C4F5B496-FE36-E567-E040-BB89AD432C45","latestVersionIndicator":"Yes","beginDate":"2012-07-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-07-16","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":"Released per approval by T.Lichtenberg. mc 7/24/12","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3527937","version":"1","preferredName":"Tumor Measurement Value","preferredDefinition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias._Annotation used to indicate the size or magnitude of something that was determined by comparison to a standard._A numerical quantity measured or assigned or computed.","longName":"3527937v1.0","context":"NCIP","contextVersion":"1","type":"Non-enumerated","dataType":"NUMBER","unitOfMeasure":"cm","minLength":"6","maxLength":"14","minValue":null,"maxValue":null,"decimalPlace":"2","PermissibleValues":[],"ConceptualDomain":{"publicId":"2008548","version":"1","preferredName":"Tumor Measurements","preferredDefinition":"any measurements, including linear dimensions, volume, and weight, of a patient's tumor.","longName":"TUMOR_MSRMTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B228CD1A-3A0C-4C11-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3527936","version":"1","preferredName":"Neoplasm Measurement Value","preferredDefinition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.:Annotation used to indicate the size or magnitude of something that was determined by comparison to a standard.:A numerical quantity measured or assigned or computed.","longName":"C3262:C25209:C25712","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Neoplasm","conceptCode":"C3262","definition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Measurement","conceptCode":"C25209","definition":"Annotation used to indicate the size or magnitude of something that was determined by comparison to a standard.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Value","conceptCode":"C25712","definition":"A numerical quantity measured or assigned or computed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C4F5B496-FE74-E567-E040-BB89AD432C45","latestVersionIndicator":"Yes","beginDate":"2012-07-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-07-16","modifiedBy":"ONEDATA","dateModified":"2012-07-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C4F5B496-FE85-E567-E040-BB89AD432C45","latestVersionIndicator":"Yes","beginDate":"2012-07-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-07-16","modifiedBy":"COOPERM","dateModified":"2012-07-24","changeDescription":"Created for TCGA per request by T.Lichtenberg. mc 7/16/12 Released per approval 7/24/12 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2756809","version":"1","longName":"TCGA (The Cancer Genome Atlas)","context":"NCIP","ClassificationSchemeItems":[{"publicId":"6044923","version":"1","longName":"Active CDEs as of March 2017","context":"NCIP"}]},{"publicId":"3787498","version":"1","longName":"TCGA 2.6 by Disease","context":"NCIP","ClassificationSchemeItems":[{"publicId":"3787518","version":"1","longName":"SARC","context":"NCIP"}]}],"AlternateNames":[{"name":"pathologic_tumor_length","type":"TCGA_XML_Name","context":"NCIP"}],"ReferenceDocuments":[{"name":"Pathologic Length of New Tumor","type":"Preferred Question Text","description":"Pathologic Length of New Tumor","url":null,"context":"NCIP"},{"name":"TCGA Form Instruction","type":"COMMENT","description":"This should include both well-differentiated and de-differentiated components.","url":null,"context":"NCIP"}],"origin":"TCGA:The Cancer Genome Atlas","workflowStatus":"RELEASED","registrationStatus":"Application","id":"C4F78E7A-0C71-672E-E040-BB89AD435D62","latestVersionIndicator":"Yes","beginDate":"2012-07-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-07-16","modifiedBy":"TSESU","dateModified":"2018-07-16","changeDescription":"Released per approval by T.Lichtenberg. mc 7/24/12","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}